Sermorelin — Indexed Studies

A potentially effective drug for patients with recurrent glioma: sermorelin.

Chang Y, Huang R, Zhai Y et al.

Impairment of GH responsiveness to combined GH-releasing hormone and arginine administration in adult patients with Prader-Willi syndrome.

Grugni G, Marzullo P, Ragusa L et al.

Polyethylene glycol-conjugated growth hormone-releasing hormone is long acting and stimulates GH in healthy young and elderly subjects.

Munafo A, Nguyen TX, Papasouliotis O et al.

Blockade of endogenous growth hormone-releasing hormone receptors dissociates nocturnal growth hormone secretion and slow-wave sleep.

Jessup SK, Malow BA, Symons KV et al.

The GH response to low-dose bolus growth hormone-releasing hormone (GHRH(1-29)NH2) is attenuated in patients with longstanding post-irradiation GH insufficiency.

Achermann JC, Brook CG, Hindmarsh PC

Quantitative growth hormone secretion and final adult height.

Trainer PJ, Palermo M, Kirk JM et al.

The relative roles of continuous growth hormone-releasing hormone (GHRH(1-29)NH2) and intermittent somatostatin(1-14)(SS) in growth hormone (GH) pulse generation: studies in normal and post cranial irradiated individuals.

Achermann JC, Hindmarsh PC, Robinson IC et al.

Growth hormone (GH)-releasing peptide-6 requires endogenous hypothalamic GH-releasing hormone for maximal GH stimulation.

Pandya N, DeMott-Friberg R, Bowers CY et al.

Enhanced growth hormone (GH) responsiveness to GH-releasing hormone after dietary restriction in patients with Cushing's syndrome.

Leal-Cerro A, Venegas E, Garcia-Pesquera F et al.

Growth hormone secretion elicited by GHRH, GHRP-6 or GHRH plus GHRP-6 in patients with microprolactinoma and macroprolactinoma before and after bromocriptine therapy.

Popovic V, Simic M, Ilic L et al.

Interaction of the growth hormone releasing peptide hexarelin with somatostatin.

Massoud AF, Hindmarsh PC, Brook CG

Effects of [norleucine27]growth hormone-releasing hormone (GHRH) (1-29)-NH2 administration on the immune system of aging men and women.

Khorram O, Yeung M, Vu L et al.

Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women.

Khorram O, Laughlin GA, Yen SS

Growth hormone release by the novel GH releasing peptide hexarelin in patients with homozygous beta-thalassemia.

Tolis G, Karydis I, Markousis V et al.

Impairment of growth hormone responsiveness to growth hormone releasing hormone and pyridostigmine in patients affected by Prader-Labhardt-Willi syndrome.

Beccaria L, Benzi F, Sanzari A et al.

Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy. Geref International Study Group.

Thorner M, Rochiccioli P, Colle M et al.

Plasma GH responses to human GHRH-antagonist in normal subjects.

Hanew K, Tanaka A, Utsumi A et al.

Growth hormone (GH)-releasing effects of synthetic peptide GH-releasing peptide-2 and GH-releasing hormone (1-29NH2) in children with GH insufficiency and idiopathic short stature.

Tuilpakov AN, Bulatov AA, Peterkova VA et al.

GH responses to intravenous bolus infusions of GH releasing hormone and GH releasing peptide 2 separately and in combination in adult volunteers.

Tiulpakov AN, Brook CG, Pringle PJ et al.

Low-dose growth hormone-releasing hormone tests: a dose-response study.

Spoudeas HA, Winrow AP, Hindmarsh PC et al.

A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding: a critical review.

Coutinho LFD, DE Oliveira Neves LF, Camilo RP

Analysis of growth hormone releasing hormone and its analogs in urine using nano liquid chromatography coupled with quadrupole/orbitrap mass spectrometry.

Uçaktürk E, Nemutlu E

Growth hormone - releasing hormone antagonists induce autophagy in cancer cells.

Sigdel M, Fakir S, Sarker MMR et al.

Growth Hormone-Releasing Hormone Antagonists Increase Radiosensitivity in Non-Small Cell Lung Cancer Cells.

Gesmundo I, Pedrolli F, Giglioli FR et al.

Antagonist of Growth Hormone-Releasing Hormone Receptor MIA-690 Suppresses the Growth of Androgen-Independent Prostate Cancers.

Muñoz-Moreno L, Gómez-Calcerrada MI, Arenas MI et al.

Exploring the role of GHRH antagonist MIA-602 in overcoming Doxorubicin-resistance in acute myeloid leukemia.

Gaumond SI, Abdin R, Costoya J et al.

Chromatographic-mass spectrometric analysis of peptidic analytes (2-10 kDa) in doping control urine samples.

Thomas A, Walpurgis K, Thevis M

Growth hormone-releasing hormone receptor antagonist MIA-602 attenuates cardiopulmonary injury induced by BSL-2 rVSV-SARS-CoV-2 in hACE2 mice.

Condor Capcha JM, Kamiar A, Robleto E et al.

Cationic exchange SPE combined with triple quadrupole UHPLC-MS/MS for detection of GHRHs in urine samples.

Cristea CD, Radu M, Toboc A et al.

In-house standards derived from doping peptides: Enzymatic and serum stability and degradation profile of GHRP and GHRH-related peptides.

González-López NM, Guerra-Acero-Turizo LM, Blanco-Medina I et al.

Growth hormone-releasing hormone antagonist MIA-602 inhibits inflammation induced by SARS-CoV-2 spike protein and bacterial lipopolysaccharide synergism in macrophages and human peripheral blood mononuclear cells.

Granato G, Gesmundo I, Pedrolli F et al.

GHRH agonist MR-409 protects β-cells from streptozotocin-induced diabetes.

Louzada RA, Blandino-Rosano M, Flores S et al.

Online large volume sample staking preconcentration and separation of enantiomeric GHRH analogs by capillary electrophoresis.

Otin J, Tran NT, Benoit A et al.

Probing for peptidic drugs (2-10 kDa) in doping control blood samples.

Thomas A, Thilmany S, Hofmann A et al.

Tumorigenic transformation of human prostatic epithelial cell line RWPE-1 by growth hormone-releasing hormone (GHRH).

Muñoz-Moreno L, Carmena MJ, Prieto JC et al.

An antibody-free, ultrafiltration-based assay for the detection of growth hormone-releasing hormones in urine at low pg/mL concentrations using nanoLC-HRMS/MS.

Coppieters G, Deventer K, Polet M et al.

Synthesis of potent antagonists of receptors for growth hormone-releasing hormone with antitumor and anti-inflammatory activity.

Cai R, Zhang X, Wang H et al.

Impact of growth hormone-releasing hormone antagonist on decidual stromal cell growth and apoptosis in vitro†.

Wu HM, Chen LH, Schally AV et al.

Advances in the detection of growth hormone releasing hormone synthetic analogs.

Memdouh S, Gavrilović I, Ng K et al.

Effects of growth hormone-releasing hormone receptor antagonist MIA-602 in mice with emotional disorders: a potential treatment for PTSD.

Recinella L, Chiavaroli A, Orlando G et al.

Effects of growth hormone-releasing hormone agonistic analog MR-409 on insulin-secreting cells under cyclopiazonic acid-induced endoplasmic reticulum stress.

Rodrigues-Dos-Santos K, Soares GM, Guimarães DSPSF et al.

Agonist of growth hormone-releasing hormone enhances retinal ganglion cell protection induced by macrophages after optic nerve injury.

Cen LP, Ng TK, Liang JJ et al.

Growth hormone-releasing hormone antagonistic analog MIA-690 stimulates food intake in mice.

Recinella L, Chiavaroli A, Orlando G et al.

Growth hormone-releasing hormone agonists ameliorate chronic kidney disease-induced heart failure with preserved ejection fraction.

Rieger AC, Bagno LL, Salerno A et al.

Comparison of magnetic bead surface functionalities for the immunopurification of growth hormone-releasing hormones prior to liquid chromatography-high resolution mass spectrometry.

Pont L, Alechaga É, Terrero A et al.

GHRH Antagonists Protect Against Hydrogen Peroxide-Induced Breakdown of Brain Microvascular Endothelium Integrity.

Barabutis N, Akhter MS, Uddin MA et al.

A glimpse at growth hormone-releasing hormone cosmos.

Barabutis N

Splice variant of growth hormone-releasing hormone receptor drives esophageal squamous cell carcinoma conferring a therapeutic target.

Xiong X, Ke X, Wang L et al.

Signaling mechanisms of growth hormone-releasing hormone receptor in LPS-induced acute ocular inflammation.

Liang WC, Ren JL, Yu QX et al.

Antinflammatory, antioxidant, and behavioral effects induced by administration of growth hormone-releasing hormone analogs in mice.

Recinella L, Chiavaroli A, Orlando G et al.